Novo Nordisk Sues Eli Lilly Over 'False and Misleading' Adverts for Weight-Loss and Anti-Diabetes Treatments
Ozempic maker Novo Nordisk has initiated a lawsuit against rival Eli Lilly, alleging 'false and materially misleading' advertisements for Lilly's competing weight-loss and anti-diabetes treatments.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.